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imaging as an assessment of diastolic
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and Rasmus Møgelvang3
Abstract
Background: The current method for a non-invasive assessment of diastolic dysfunction is complex with the use of
algorithms of many different echocardiographic parameters. Total average diastolic longitudinal displacement (LD),
determined by colour tissue Doppler imaging (TDI) via the measurement of LD during early diastole and atrial
contraction, can potentially be used as a simple and reliable alternative.
Methods: In 206 patients, using GE Healthcare Vivid E7 and 9 and Echopac BT11 software, we determined both
diastolic LD, measured in the septal and lateral walls in the apical 4-chamber view by TDI, and the degree of
diastolic dysfunction, based on current guidelines. Of these 206 patients, 157 had cardiac anomalies that could
potentially affect diastolic LD such as severe systolic heart failure (n = 45), LV hypertrophy (n = 49), left ventricular
(LV) dilation (n = 30), and mitral regurgitation (n = 33). Intra and interobserver variability of diastolic LD measures
was tested in 125 patients.
Results: A linear relationship between total average diastolic LD and the degree of diastolic dysfunction was found.
A total average diastolic LD of 10 mm was found to be a consistent threshold for the general discrimination of
patients with or without diastolic dysfunction. Using linear regression, total average diastolic LD was estimated to
fall by 2.4 mm for every increase in graded severity of diastolic dysfunction (β = −0.61, p-value <0.001). Patients with
LV hypertrophy had preserved total average diastolic LD despite being classified as having diastolic dysfunction.
Reproducibility of LD measures was acceptable.
Conclusions: There is strong evidence suggesting that patients with a total average diastolic LD under 10 mm
have diastolic dysfunction.
Keywords: Echocardiography, Colour tissue Doppler imaging, Diastolic function, Diastolic longitudinal displacement
Background
There is no simple means of reliably diagnosing left ven-
tricular (LV) diastolic dysfunction: The current method
for a non-invasive assessment of diastolic function re-
quires the use of algorithms primarily based on a pulsed
Doppler measurement of early mitral inflow velocity (E)
and a colour tissue Doppler imaging (TDI) assessment
of early mitral annular velocity (e’), thereby giving an
indirect assessment of LV filling pressures (E/e’), as
determined by the Bernouili principle and Laplace law
[1]. Other parameters include an assessment of early and
atrial mitral inflow patterns (E/A), deceleration time
(DT), and left atrial (LA) volume [2]. Using these param-
eters, LV diastolic dysfunction is traditionally classified
as grade 1: abnormal relaxation; grade 2: pseudonormal
relaxation, or grade 3: restrictive filling pattern.* Correspondence: martinadeknegt@gmail.com
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Even though it is agreed that no single current
echocardiographic measure is sufficient for a diagnosis
of LV diastolic dysfunction, the use of algorithms of
many different echocardiographic parameters is also
problematic as a situation of “one size fits all” arises.
Additionally, the fundamental use of velocity based
parameters in these algorithms is deficient as the use of
velocities as a determinant of diastolic function only
takes one snapshot of imaging into consideration,
thereby making an accurate depiction of severity difficult
to obtain, especially in patients with atrial fibrillation.
Lastly, the echocardiographic parameters used in these
algorithms are only estimates of LV filling pressures and
are subject to limitations of the imaging technique, such
as angle dependency, sample volume, and tethering arti-
facts as well as to shortcomings inherent to derivation of
pressures from inflow or re-extension signals [1].
Furthermore, the reliability, feasibility, and practical util-
ity of the individual markers of diastolic dysfunction have
been questioned and concordance has been shown to be
poor [3, 4]. With regards to e’, septal and lateral measure-
ments differ and it has, therefore, been recommended that
averages be used [5]. e’ can also be reduced inaccurately
by mitral annular calcification, surgical rings, or prosthetic
valves [1]. With regards to E/e’, pulsed Doppler velocities
have been shown to overestimate colour TDI velocities,
thereby, potentially leading to error in the assessment of
LV diastolic function [6]. The use of E/e’ has also been
questioned in patients with hypertrophic and dilated car-
diomyopathy and in decompensated patients with resyn-
chronization therapy [7, 8]. Moreover, E/e’ >15 is
associated with an elevated LV filling pressure and E/e’ <8
is evidence of normal filling pressure - there is, therefore,
a big gap (between E/e' 8-15) for which additional investi-
gations are required to obtain a LV filling pressure esti-
mate [1]. The use of E/A and DT is also problematic as
both measures are bimodal and a situation with pseudo-
normalisation occurs, making it difficult to discern be-
tween a patient with normal diastolic function and a
patient with a relatively severe grade of diastolic
dysfunction.
Our group has previously shown that a combined
assessment of both early and late diastolic velocities by
colour TDI is a strong prognostic marker of acute myo-
cardial infarction, heart failure, and cardiovascular death
in the general population [9]. This indicates that an as-
sessment of both early and late diastole is important for
a meaningful assessment of true LV diastolic function.
Total diastolic longitudinal displacement (LD) calculated
via the integration of the early (E) and atrial (A) velocity
waves, obtained by colour TDI, is a potentially new
measurement of diastolic function that avoids the major
drawbacks associated with the current velocity based
assessment, namely an independent measurement that
has a linear relationship with the degree of diastolic
dysfunction, i.e. non-biphasic, and a measurement that
takes the whole diastolic process into consideration, i.e.
not just a snapshot of imaging.
The aims of this study are to investigate: 1) The poten-
tial of colour TDI determined total diastolic LD in the
determination of diastolic function in the healthy and
dysfunctional heart, 2) The ability of total diastolic LD
to predict adverse outcomes, 3) To assess reproducibility
of total diastolic LD.
Methods
Data source
The Department of Cardiology, Herlev and Gentofte
Hospital, University of Copenhagen performs routine
echocardiograms according to a standardised protocol
and these echocardiograms are stored on a local server.
Study population
A total of 486 consecutive patients were retrieved from
the echocardiogram database. To obtain a representation
of structural heart disease (no cardiac abnormalities;
severe systolic heart failure; LV hypertrophy; LV dilation;
and mitral regurgitation), the echocardiograms were
analysed in accordance with the following criteria:
Inclusion criteria:
– No cardiac abnormalities: Eyeball LVEF >50 % and
normal cardiac dimensions.
– Severe systolic heart failure: Eyeball LVEF <30 %.
– LV hypertrophy: LV mass/body surface area ≥113 g/
m2 for women and ≥131 g/m2 for men.
– LV dilation: LV internal dimension at end-diastole/
body surface area ≥3.8 cm/m2 for women and
≥3.7 cm/m2 for men.
– Mitral regurgitation: ≥grade 2.
Exclusion criteria:
– Overlapping diseases of the above mentioned, for
example, mitral regurgitation in a patient with LV
hypertrophy. Exceptions: patients with a dilated LV,
hypertrophic LV, or mitral regurgitation may have
had a LVEF under 30 %.
– Incomplete examinations.
– Bundle branch block.
– Atrial fibrillation.
– Unsuitability for colour TDI, i.e. indistinguishable E-
and A-wave.
A total of 89 patients fulfilled inclusion criteria for “no
cardiac abnormalities”; 138 patients fulfilled inclusion cri-
teria for “severe systolic heart failure”; 117 patients fulfilled
criteria for “LV hypertrophy”; 75 patients fulfilled inclusion
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criteria for “LV dilation”; and 67 patients fulfilled criteria
for “mitral regurgitation”. After application of exclusion
criteria, the final study population consisted of 206 pa-
tients, 49 of whom were classified as having normal cardiac
dimensions and function. The 157 remaining patients all
had heart anomalies that could potentially affect diastolic
LD such as severe systolic heart failure (n = 45), LV
hypertrophy (n = 49), LV dilation (n = 30), and mitral
regurgitation (n = 33). Diastolic function was assessed and
participants were graded as having a normal relaxation
(n = 76), abnormal relaxation (n = 75), pseudonormal
relaxation (n = 44), or restrictive filling pattern (n = 11).
Echocardiographic analyses
All echocardiograms were obtained using Vivid E7 and
Vivid 9 ultrasound systems (GE Healthcare, Horten
Norway) and all images were stored digitally on a central
server. All participants were examined with conventional
two-dimensional echocardiography, m-mode, pulsed-
wave TDI, colour TDI and two-dimensional strain
imaging. All the echocardiographic analyses in the
present study were performed de novo and offline
(blinded to other clinical data) using Echopac BT11
software (GE Healthcare, Horten Norway).
Conventional echocardiography
LV end-diastolic dimensions (interventricular septum
wall thickness (IVS), LV internal dimension (LVID), and
LV posterior wall thickness (PWT)) and LA diameter
were obtained from the parasternal long-axis view at the
mitral valve leaflet tips. Pulsed wave Doppler was used
to record mitral inflow between the tips of the mitral
leaflets. LVEF was obtained using modified Simpson’s
biplane method in the 4-chamber and 2-chamber view
[10]. LA volume was estimated by the area-length
method [10]. LV mass index was calculated as the
anatomic mass (LV mass = 0.8x(1.04[(IVSd + LVIDd +
PWTd)3 − LVIDd3]) + 0.6 g) [11], divided with body
surface area. All measurements were acquired from the
parasternal approach and measured at the level of the
mitral valve at end-diastole. Relative wall thickness was
calculated as (2 × LV PWT)/(LVID) and the subgroup of
patients with LV hypertrophy was sub-categorized with
regards to concentric or eccentric hypertrophy in ac-
cordance with current American Society of Echocardiog-
raphy Committee recommendations [10]. Severity of
mitral regurgitation was determined according to
current guidelines [12]. All chamber quantifications are
in accordance with the American Society of Echocardi-
ography Committee recommendations [10].
Tissue Doppler Imaging (TDI)
Colour TDI loops were obtained in the apical 4-chamber
view. Peak longitudinal systolic velocities (s’) as well as
early diastolic (e’) and late diastolic (a’) velocities were
measured in the septal and lateral wall using a 5 mm
circular sample volume placed in the left ventricular
myocardial just proximal to the mitral annular level.
Total average systolic and diastolic LD was determined
by calculating the area under the curve, using tissue
tracking software, of the systolic, early and late diastolic
waves, respectively, and averaging septal and lateral
findings (Fig. 1). Potential L-waves between the early
and late diastolic waves were not included in the assess-
ment of total average diastolic displacement. Systolic
displacement was measured as the maximal displace-
ment between aortic valve opening and aortic valve
closure and post-systolic contraction was not included
in systolic displacement measurements.
Pulsed wave TDI tracings, used to measure peak
myocardial velocities, were obtained with the range gate
placed at the septal and lateral mitral annular segments
in the 4-chamber view. The average of septal and lateral
e’ by pulsed wave TDI was used to calculate E/e’.
M-mode
Mitral annular plane systolic excursion (MAPSE) was
determined in the septal and lateral walls in the apical
four-chamber view in all participants. This was done by
placing the M-mode cursor in the septal and lateral bor-
ders in the mitral annular plane. In doing so, an image
of either septal or lateral mitral annular displacement
was obtained. MAPSE was measured from the lowest to
the highest point of contraction, excluding post-systolic
contractions, i.e. measurements were obtained between
aortic valve opening and aortic valve closure.
Two-dimensional Strain Imaging (2DSI)
Using 2-dimensional speckle tracking derived strain
imaging, the left ventricular myocardial wall was traced
in the 4-chamber view with the basal septal and lateral
segments starting at the mitral annular level. By the
tracking of speckles from frame-to-frame, myocardial
deformation was assessed. The average of regional
measurements in a 6-segment model from the apical
4-chamber view was used as an estimate of longitudinal
displacement (LD), longitudinal strain (LS) and longitu-
dinal strain rate (LSR). Regional basal longitudinal
displacement, strain, and strain rate was calculated as
the average of the basal septal and lateral segments in
the apical 4-chamber view.
TDI and strain measurements are reported as absolute
values.
Determination of degree of diastolic dysfunction
Patients were graded as having either normal diastolic
function or abnormal diastolic function grade 1–3
according to current EAE/ASE recommendations [2].
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Prognostics study
Data on mortality (primary endpoint) was obtained
using the unique personal identification number in the
Central Office of Civil Registration and the Danish Na-
tional Board of Health’s National Patient Registry.
Statistical analysis
All statistical analyses were done using SPSS version 20
(SPSS, Inc, Chicago, IL). In Table 1, continuous Gaussian
distributed variables and proportions were compared
using Student’s t-test and χ2-test, respectively. Pearsons
correlation was used to determine any associations be-
tween the degree of diastolic dysfunction and total average
diastolic LD as well as between total average diastolic LD
and individual parameters used in the assessment of
diastolic and systolic function. Using logistic regressions,
odds ratios for unadjusted and adjusted models were
calculated to establish the association between peak vel-
ocities and diastolic LD and the primary endpoint (death).
Interactions with the subgroup type were tested for.
Bland-Altman analysis was used to evaluate intraobserver
and interobserver variability and was expressed as mean
difference ± 1.96 standard deviation (SD) and as coeffi-
cient of variation (CV) [13]. P-values <0.05 in two-sided
tests were considered statistically significant.
Results
Patient characteristics
Main characteristics of the study population are presented
in Table 1. Parameters of advanced echocardiography are
presented in Table 2. Compared to controls, patients with
structural heart disease had both reduced early and active
diastolic function as assessed by various echocardio-
graphic techniques such as TDI and speckle tracking. Of
the 49 patients with LV hypertrophy, 32 (65 %) had con-
centric hypertrophy; 17 (35 %) had eccentric hypertrophy.
Total average diastolic longitudinal displacement and
degree of diastolic dysfunction
A linear relationship, also after adjustment for age and
gender, between total average diastolic LD and the degree
of diastolic dysfunction was found (Fig. 2). This linear
relationship is due to a fall in TT-e’ in the mild stages of
diastolic dysfunction and TT-a’ which only starts to
diminish at more severe degrees of diastolic dysfunction
(Additional file 1: Figure S1 and S2). This linear relation-
ship indicates the value of total average diastolic LD as an
indicator of LV diastolic function and a total average
diastolic LD of 10 mm was found to be a consistent thresh-
old for the general discrimination of patients with or
without diastolic dysfunction. This threshold was chosen
on the basis of findings in Fig. 3 where the vast majority of
controls with normal diastolic function had a total average
diastolic LD above 10 mm. Pearson correlation was
calculated to be −0.61 with a p-value <0.001. Using linear
regression, total average diastolic LD was estimated to fall
by 2.4 mm for every increase in graded severity of diastolic
dysfunction (β = −0.61, p-value <0.001). A similar relation-
ship was found when investigating total average diastolic
velocity (e’ + a’) and degree of diastolic function (Pearson
Fig. 1 Image of colour tissue Doppler imaging with septal longitudinal displacement measurements depicted as area under the curve in early
and late diastole. s’, peak mitral annular systolic velocity; e’, peak early mitral annular diastolic velocity; a’, peak atrial mitral annular diastolic velocity;
AVO, aortic valve opening; AVC, aortic valve closing
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correlation 0.63, p-value <0.001), although a cutoff of
12 cm/s is appropriate here (Additional file 1: Figure S3).
Total average diastolic longitudinal displacement in
various heart conditions
Figure 3 illustrates findings of total average diastolic LD in
various heart conditions in comparison to the degree of
diastolic dysfunction. Median values of all participants
classified as having normal diastolic function had a total
average diastolic LD above 10 mm, except for patients
with severe systolic heart failure. A closer examination of
the patients with severe systolic heart failure with normal
diastolic function as determined by current guidelines [2]
revealed that patients with a diastolic LD ≥10 mm had
reduced markers of systolic function (mean LS = −11.5 ±
7.1 %; mean LSR = −0.85 ± 0.2 s−1; and mean systolic LD
by TDI (TT-s’) = 10.7 ± 1.5 mm). Systolic function of indi-
viduals with severe systolic heart failure, normal diastolic
function, and a diastolic LD <10 mm was also reduced,
but to a greater degree (LS = −9.9 ± 5.7 %, LSR = −0.68 ±
0.32 s−1, TT-s’ = 7.0 ± 1.7 mm).
Generally, median values of mean diastolic LD fell
with increasing severity of diastolic dysfunction for all
subgroups except for the control group and patients
with LV hypertrophy, who both had a preserved total
average diastolic LD ≥10 mm despite being categorised
as having an abnormal relaxation pattern. Median values
of all participants classified as having either a pseudo-
normal or restrictive filling pattern had a total average
diastolic LD <10 mm. Table 3 shows the configuration
of the E- and A-waves in controls and in patients with
LV hypertrophy and an abnormal relaxation pattern. In
both groups, peak velocities for the A-wave were greater
than for the E-wave but displacement in the E- and
A-waves for each was roughly equal, indicating that
these two groups had low, broad E-waves and tall,
narrow A-waves.
A further analysis of controls with grade 1 diastolic
dysfunction and a diastolic LD ≥10 mm revealed that
the sole reason for these individuals being classified as
having grade 1 diastolic dysfunction was a lateral e’
<10 cm/s or septal e’ <8 cm/s and not enlarged atriums
(LA volume <34 ml/m2).
Table 4 shows the correlation of average diastolic and
systolic LD measures with peak average diastolic and
systolic velocities for subjects with LV hypertrophy and
Table 1 Characteristics of the patients studied
Controls (n = 49) Severe Systolic HF (n = 45) LV Hypertrophy (n = 49) LV Dilation (n = 30) Mitral Regurgitation (n = 33)
Age, y 58 ± 15 65 ± 15* 69 ± 15*** 76 ± 9*** 71 ± 11***
Male sex, % (n) 43 (21) 93 (42) 47 (23) 57 (17) 55 (18)
Height, cm 173 ± 9 177 ± 9* 171 ± 10 167 ± 7** 171 ± 9
Weight, kg 76 ± 16 82 ± 15 73 ± 14 65 ± 14** 72 ± 15
LVIDd, cm 4.7 ± 0.6 5.6 ± 0.7*** 5.2 ± 0.7** 6.8 ± 0.8*** 5.0 ± 0.9
BSA, m2 1.9 ± 0.2 2.0 ± 0.2* 1.8 ± 0.2 1.7 ± 0.2*** 1.8 ± 0.2
LVIDd/BSA, cm/m2 2.5 ± 0.3 2.9 ± 0.4*** 2.8 ± 0.4*** 4.0 ± 0.2*** 2.7 ± 0.5*
LVEF, % 64 ± 7 30 ± 9*** 60 ± 7* 25 ± 12*** 53 ± 16***
IVS, cm 0.9 ± 0.2 0.9 ± 0.2 1.2 ± 0.2*** 1.0 ± 0.2 1.0 ± 0.3
LVPWd, cm 0.9 ± 0.2 0.9 ± 0.2 1.2 ± 0.2*** 1.0 ± 0.1 1.0 ± 0.3
LVM/BSA, g/m2 70 ± 16 102 ± 19*** 130 ± 23*** 171 ± 42*** 103 ± 37**
DDF 0, % (n) 74 (36) 24 (11) 35 (17) 0 (0) 36 (12)
DDF 1, % (n) 22 (11) 51 (23) 39 (19) 47 (14) 24 (8)
DDF 2, % (n) 4 (2) 11 (5) 27 (13) 47 (14) 30 (10)
DDF 3, % (n) 0 (0) 13 (6) 0 (0) 7 (2) 9 (3)
E/A 1.2 ± 0.5 1.2 ± 0.8 1.1 ± 0.5 1.4 ± 1.0 1.5 ± 0.6**
DT, ms 221 ± 57 191 ± 98 236 ± 59 218 ± 66 223 ± 93
LAV, ml/m2 24.5 ± 9.0 33.8 ± 10.5*** 39.6 ± 13.7*** 45.5 ± 18.2*** 46.5 ± 16.5***
E/e’ 8.6 ± 3.6 12.3 ± 6.4** 12.4 ± 5.4*** 17.0 ± 7.9*** 19.3 ± 14.9***
Known IHD, % (n) 18 (9) 69 (31) 4 (2) 17 (5) 21 (7)
HF heart failure, LV Left ventricular, LVIDd LV internal dimension in diastole, BSA body surface area, LVEF LV ejection fraction, IVS interventricular septum, LVPWd LV
posterior wall in diastole, LVM LV mass, DDF degree of diastolic dysfunction, E/A early inflow velocity/atrial inflow velocity, DT deceleration time, LAV left atrial
volume, E/e’ early inflow velocity/early diastolic tissue velocity, IHD ischemic heart disease
*P <0.05 compared with the control group
**P <0.01 compared with the control group
***P <0.001 compared with the control group
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varying degrees of diastolic dysfunction. A moderate
correlation was found between total average systolic LD
and total average diastolic LD as well as between peak
longitudinal systolic velocity by TDI (s’) and total aver-
age diastolic LD, especially in patients with normal dia-
stolic function and in patients with abnormal relaxation.
An examination of parameters of systolic function in
patients with LV hypertrophy indicates preserved systolic
function (LVEF = 60 ± 7 %, LSR = −0.92 ± 0.35 s−1, LS =
12.0 ± 3.8, TT-s’ = 10.8 ± 2.0 mm, s’ = 5.38 ± 1.14 cm/s).
Left ventricular ejection fraction and total average
diastolic longitudinal displacement
Figure 4 illustrates the relationship of total average
diastolic LD with LVEF. Participants are clustered into
two main groups: a group with a total average diastolic
LD <10 mm and a LVEF <50 % and a group with a total
average diastolic LD >10 mm and a LVEF >50 %, and
two smaller groups: a group with total average diastolic
LD <10 mm and an LVEF >50 % and a group with a
total average diastolic LD >10 mm and an LVEF <50 %.
By examining the colour combinations of subjects in
Fig. 4, it can be seen that the vast majority of subjects
with no diastolic dysfunction have a LVEF >50 % and a
diastolic LD >10 mm while the vast majority of subjects
with grade 3 diastolic dysfunction have a LVEF <50 %
and a diastolic LD <10 mm.
Regarding subjects with a LVEF >50 % and a diastolic
LD <10 mm, it can be seen that almost all subjects have
some degree of diastolic dysfunction. A comparison of
longitudinal systolic function of these subjects, i.e. patients
with LVEF >50 % and diastolic LD <10 mm (n = 32),
compared to subjects with LVEF >50 % and diastolic LD
>10 mm (n = 88) revealed that systolic function was
reduced in this group: LS = −12.3 ± 4.1 %, LSR = −0.86 ±
0.33 s−1, TT-s’ = 9.2 ± 1.8 mm and s’ = 4.8 ± 1.0 cm/s
Table 2 Advanced echocardiographic parameters within subgroups
Controls
(n = 49)
Severe Systolic HF
(n = 45)
LV Hypertrophy
(n = 49)
LV Dilation
(n = 30)
Mitral Regurgitation
(n = 33)
TDI
s’, cm/s 6.2 ± 1.4 3.8 ± 1.2*** 5.4 ± 1.1** 2.9 ± 1.1*** 5.3 ± 2.3
e’, cm/s −7.6 ± 2.3 −4.4 ± 1.6*** −5.9 ± 2.2*** −3.6 ± 1.7*** −5.3 ± 2.5***
a’, cm/s −7.6 ± 1.8 −5.7 ± 2.3*** −6.8 ± 1.7* −4.3 ± 2.0*** −5.6 ± 2.6***
e’ + a’, cm/s −15.2 ± 2.7 −10.1 ± 2.5*** −12.7 ± 2.2*** −7.9 ± 2.7*** −11.0 ± 4.6***
TT-s’, mm 11.4 ± 2.0 6.5 ± 2.3*** 10.8 ± 2.0 4.7 ± 2.5*** 9.3 ± 4.3*
TT-e’, mm 7.3 ± 2.2 3.6 ± 1.8*** 5.6 ± 2.1*** 2.6 ± 1.2*** 4.8 ± 2.6***
TT-a’, mm 5.2 ± 1.5 4.0 ± 1.7*** 5.2 ± 1.5 3.1 ± 1.6*** 4.2 ± 1.9**
TT-e’ + TT-a’, mm 12.6 ± 2.3 7.5 ± 2.2*** 10.8 ± 2.2*** 5.7 ± 1.9*** 9.0 ± 4.0***
M-mode
MAPSE, mm 12.3 ± 2.4 7.4 ± 2.1*** 11.3 ± 2.0* 5.4 ± 2.2*** 10.4 ± 4.1*
2D strain
LS, % −14.8 ± 3.8 −9.1 ± 4.5*** −12.0 ± 3.8** −6.6 ± 4.3*** −12.1 ± 4.8**
LD, mm 15.4 ± 2.6 7.7 ± 3.0*** 15.8 ± 3.0 6.1 ± 3.8*** 12.7 ± 5.7*
s, cm/s 6.5 ± 1.5 4.0 ± 1.0*** 5.7 ± 1.0** 2.5 ± 2.0*** 5.0 ± 1.9***
e, cm/s −6.5 ± 2.8 −3.8 ± 1.6*** −5.4 ± 2.1* −2.3 ± 1.9*** −5.3 ± 2.7
a, cm/s −7.4 ± 1.7 −5.3 ± 1.9*** −6.5 ± 2.0* −4.1 ± 1.8*** −5.4 ± 2.2***
e + a, cm/s −13.9 ± 3.2 −9.1 ± 2.3*** −11.9 ± 2.6** −6.5 ± 3.0*** −10.7 ± 4.3**
s, s−1 −1.0 ± 0.3 −0.8 ± 0.2*** −0.9 ± 0.4 −0.8 ± 0.3** −1.0 ± 0.4
e, s−1 1.3 ± 0.4 0.9 ± 0.5*** 1.0 ± 0.3** 0.7 ± 0.4*** 1.1 ± 0.4*
a, s−1 1.2 ± 0.4 0.9 ± 0.4*** 1.1 ± 0.5 0.9 ± 0.5** 1.1 ± 0.4
e + a, s−1 2.5 ± 0.5 1.8 ± 0.6*** 2.2 ± 0.7* 1.6 ± 0.8*** 2.1 ± 0.7**
TDI tissue Doppler Imaging, s’ systolic tissue velocity by TDI measured at the mitral annulus, e’ early diastolic tissue velocity by TDI measured at the mitral annulus,
a’ late diastolic tissue velocity by TDI measured at the mitral annulus, TT-s’ systolic displacement measured at the mitral annulus, TT-e’ early diastolic displacement
measured at the mitral annulus, TT-a’ late diastolic displacement measured at the mitral annulus, MAPSE M-mode derived mitral annular plane systolic excursion,
LS longitudinal strain by 2D strain imaging, LD longitudinal displacement by 2D strain imaging, s systolic tissue velocity/strain rate by 2D strain imaging measured
at the basal septal and lateral segments, e early diastolic tissue velocity/strain rate by 2D strain imaging measured at the basal septal and lateral segments, a late
diastolic tissue velocity/strain rate by 2D strain imaging measured at the basal septal and lateral segments
*P <0.05 compared with the control group
**P <0.01 compared with the control group
***P <0.001 compared with the control group
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compared to LS = −13.9 ± 3.9 %, LSR = −1.05 ± 0.32 s−1,
TT-s’ = 11.9 ± 2.2 mm and s’ = 6.3 ± 1.4 cm/s.
An examination of systolic function of the 4 individ-
uals with a LVEF <50 % and a diastolic LD >10 mm
revealed a LS of −11.5 ± 7.1 %, LSR = −0.78 ± 0.17 s−1,
TT-s’ = 10.8 ± 1.5 mm and s’ = 5.3 ± 1.2 cm/s. An analysis
of the comorbidities of these patients revealed that they
all suffered from ischemic heart disease.
Correlations
Pearsons correlation was used to determine the associ-
ation of average diastolic LD with a variety of other
echocardiographic parameters (Table 5). With regards to
the entire population, strong associations were found
when comparing LD in early diastole (TT-e’) with early
mitral annular velocity (e’), LD in late diastole (TT-a’)
with late mitral annular velocity (a’), total average
Fig. 2 Total average diastolic longitudinal displacement and the degree of diastolic dysfunction. HF, heart failure
Fig. 3 Total average diastolic longitudinal displacement in various heart conditions and the degree of diastolic dysfunction HF, heart failure
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diastolic LD (TT-e’ + TT-a’) with e’ + a’, and the ratio of
diastolic LD between the early and atrial wave (TT-e’/
TT-a’) with peak velocities for the early and atrial wave
(e’/a’). When considering systolic displacement mea-
sured by TDI, M-mode, and 2D strain imaging and TDI
derived total average diastolic LD, strong correlations
were found. Weaker correlations were found when
comparing total average diastolic LD to other systolic
measures, such as LVEF, LS and LSR. A comparison of
associations between groups (Table 5) reveals that the
strongest associations were seen when comparing dia-
stolic LD measurements with diastolic velocity measure-
ments. A weaker association was seen when comparing
average diastolic LD with systolic LD and velocity, and
was weakest for patients with LV hypertrophy. The
biggest fluctuations and weakest correlations between
groups were seen when determining the association of
average diastolic LD with markers of systolic func-
tion such as LVEF, LS and LSR.
Agreement with echocardiographic parameters
Figure 5 depicts the mean differences (bias) of total
average systolic and diastolic measurements plotted
against the mean of the two average LD measurements,
(Bland-Altman plot). The mean difference was calcu-
lated to −0.58 mm indicating that average systolic LD
underestimates total average diastolic LD. The limits of
agreement were calculated to ±3.46 mm and a coeffi-
cient of variation (CV) of 19 % was found.
Total average diastolic longitudinal displacement as a
predictor of adverse cardiac outcomes
There were 33 events (death) during 2.6 ± 1.2 years
follow-up. Odds ratios were calculated to determine the
predictive capabilities of total diastolic LD in compari-
son to diastolic colour TDI velocities with regards to
all-cause mortality: per unit decrease, risk of death
increased in a similar pattern for e’ + a’ and TT-e’ +
TT-a’ (Table 6). Following adjustment for covariates
(first multivariate analysis adjusted for age and gender
and second multivariate analysis adjusted for age,
gender, LVEF, LV internal dimension in diastole/body
surface area, LV mass index, and LS), e’ + a’ and TT-e’ +
TT-a’ remained significant predictors of death. LA
volume was also shown to be a significant predictor of
death, also after adjustment in multivariate analyses. The
calculation of area under the curve in ROC curves
(Fig. 6) showed similar results.
Reproducibility
Intraobserver variability for septal and lateral LD
measurements of the E-wave and A-wave was relatively
low, as is shown by the mean difference being close to
zero (Additional file 1: Figure S4). Limits of agreement
are, however, fairly wide and the largest variability, as
indicated by CV, was seen in lateral A-wave LD
measurements.
Interobserver variability findings were found to be
similar to intraobserver variability. All mean differences
were close to zero. The greatest variability was seen in
E-wave LD measurements in comparison to A-wave LD
Table 3 The configuration of the early and atrial waves in
controls and in subjects with left ventricular hypertrophy and an
abnormal relaxation pattern
Configuration Controls
Mean ± SD
LV hypertrophy
Mean ± SD
e’ (cm/s) 5.44 ± 1.46 5.11 ± 1.56
a’ (cm/s) 7.27 ± 2.41 7.86 ± 1.22
TT-e’ (mm) 5.44 ± 1.20 5.02 ± 1.51
TT-a’ (mm) 5.31 ± 1.71 6.24 ± 0.91
e’ early diastolic tissue velocity by TDI measured at the mitral annulus, a’ late
diastolic tissue velocity by TDI measured at the mitral annulus, TT-e’ early
diastolic displacement measured at the mitral annulus, TT-a’ late diastolic
displacement measured at the mitral annulus
Table 4 Correlations of total average diastolic longitudinal displacement with peak average diastolic velocities and average systolic
longitudinal displacement for subjects with LV hypertrophy and no diastolic dysfunction and a first and second degree of diastolic
dysfunction
Comparison DDF 0 DDF 1 DDF 2
Pearson Correlation P-value Pearson Correlation P-value Pearson Correlation P-value
e’ and TT-e’ 0.92 <0.001 0.77 <0.001 0.67 <0.05
a’ and TT-a’ 0.89 <0.001 0.81 <0.001 0.88 <0.001
e’ + a’ and TT-e’ + TT-a’ 0.81 <0.001 0.81 <0.001 0.88 <0.001
TT-e’/TT-a’ and e’/a’ 0.95 <0.001 0.75 <0.001 0.76 <0.001
TT-s’ and TT-e’ + TT-a’ 0.53 <0.05 0.62 <0.05 0.79 <0.001
TT-e’ + TT-a’ and s’ 0.46 0.06 0.40 0.09 0.80 <0.001
e’ early diastolic tissue velocity by TDI measured at the mitral annulus, a’ late diastolic tissue velocity by TDI measured at the mitral annulus, s’ systolic tissue
velocity by TDI measured at the mitral annulus, TT-e’ early diastolic displacement measured at the mitral annulus, TT-a’ late diastolic displacement measured at the
mitral annulus, TT-s’ systolic displacement measured at the mitral annulus
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measurements, as is indicated by the larger limits of
agreement and larger CV.
Discussion
This is the first study, to our knowledge, to investigate
total average diastolic LD determined by colour TDI as a
potential new parameter for the determination of LV
diastolic dysfunction. Our findings on the predictive
capabilities and reproducibility of this parameter are im-
portant with regards to its utilisation in clinical practice.
Tissue Doppler Imaging
TDI is a useful echocardiographic technique to evaluate
global and regional systolic and diastolic function in a
Fig. 4 Total average diastolic longitudinal displacement as a function of left ventricular ejection fraction
Table 5 Correlations of average diastolic longitudinal displacement with peak average diastolic velocities, average systolic
longitudinal displacement and other measures of systolic function for all subjects and between subgroups
Comparison All subjects Control Severe systolic HF LV hypertrophy LV dilation Mitral regurgitation
r p-value r p-value r p-value r p-value r p-value r p-value
e’ and TT-e’ 0.93 <0.001 0.90 <0.001 0.89 <0.001 0.88 <0.001 0.91 <0.001 0.95 <0.001
a’ and TT-a’ 0.92 <0.001 0.87 <0.001 0.94 <0.001 0.89 <0.001 0.90 <0.001 0.92 <0.001
e’ + a’ and TT-e’ + TT-a’ 0.94 <0.001 0.84 <0.001 0.89 <0.001 0.85 <0.001 0.88 <0.001 0.96 <0.001
TT-e’/TT-a’ and e’/a’ 0.90 <0.001 0.92 <0.001 0.87 <0.001 0.94 <0.001 0.94 <0.001 0.86 <0.001
TT-e’/TT-a’ and E/A 0.67 <0.001 0.83 <0.001 0.79 <0.001 0.87 <0.001 0.52 <0.001 0.62 <0.001
TT-s’ and TT-e’ + TT-a’ 0.88 <0.001 0.82 <0.001 0.73 <0.001 0.66 <0.001 0.76 <0.001 0.88 <0.001
s’ and TT-e’ + TT-a’ 0.85 <0.001 0.73 <0.001 0.70 <0.001 0.56 <0.001 0.78 <0.001 0.89 <0.001
e’ + a’ and s’ 0.82 <0.001 0.74 <0.001 0.74 <0.001 0.43 <0.001 0.75 <0.001 0.87 <0.001
LVEF and TT-e’ + TT-a’ 0.71 <0.001 −0.03 0.83 0.52 <0.001 0.01 0.94 0.81 <0.001 0.58 <0.001
LS and TT-e’ + TT-a’ −0.60 <0.001 −0.06 0.67 −0.50 <0.001 −0.18 0.21 −0.57 <0.001 −0.64 <0.001
LSR and TT-e’ + TT-a’ −0.41 <0.001 0.05 0.73 −0.29 0.05 −0.31 <0.05 −0.40 <0.05 −0.52 <0.001
LD and TT-e’ + TT-a’ 0.76 <0.001 0.52 <0.001 0.31 <0.05 0.33 <0.05 0.75 <0.001 0.78 <0.001
MAPSE and TT-e’ + TT-a’ 0.82 <0.001 0.63 <0.001 0.54 <0.001 0.37 <0.01 0.83 <0.001 0.84 <0.001
HF heart failure, LV left ventricular, e’ early mitral annular diastolic velocity, TT-e’ displacement in early diastole, a’ late mitral annular diastolic velocity, TT-a’
displacement in late diastole, TT-e’ + TT-a’ total average diastolic displacement; s’, mitral annular systolic velocity, TT-s’ total average systolic displacement, LVEF left
ventricular ejection fraction, LS longitudinal strain derived from the 4-chamber view, LSR longitudinal strain rate derived from the 4-chamber view, LD longitudinal
displacement derived from strain imaging in the 4-chamber view, MAPSE M-mode derived mitral annular plane systolic excursion
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variety of different cardiac conditions [14]. Even though
it is reproducible, widespread, and allows for extensive
off-line analysis [15], it is underutilised in clinical prac-
tice. Limitations of TDI include angle dependency with
possible underestimations of tissue velocities if the angle
of interrogation exceeds 20° [14] and overestimations
when using excessive gain [16]. Furthermore, difficulties
in estimating diastolic tissue velocities and displacement
arise in patients with non-discernible E and A waves, i.e.
patients with atrial fibrillation.
Total average diastolic longitudinal displacement and
degree of diastolic dysfunction
One of the major drawbacks of current diastolic parame-
ters is that there often is a biphasic element involved, as
is seen with E/A and DT. This results in difficulty in dis-
cerning between a patient with normal diastolic function
and a patient with a relatively severe grade of diastolic
dysfunction. As depicted in Fig. 2, total average diastolic
LD has a linear relationship with the degree of diastolic
dysfunction, thereby eliminating this risk of misinter-
pretation. This linear relationship is due to a fall in
TT-e’ in the mild stages of diastolic dysfunction and
TT-a’ which only starts to diminish at more severe
degrees of diastolic dysfunction (Additional file 1: Figure
S1 and S2). A total average diastolic LD of 10 mm was
found to be a consistent threshold for the general
discrimination of patients with or without diastolic
dysfunction and this can potentially be used in a clinical
situation as an independent marker for the general
evaluation of a patient’s overall diastolic function.
Furthermore, total average diastolic LD considers the
shape of the E- and A-wave and not just peak velocity
values. Theoretically, this must provide a more reliable
measurement in comparison to single snapshot based
parameters, see below.
Total average diastolic longitudinal displacement in
various heart conditions
Total average diastolic LD is a potentially superior par-
ameter for the true evaluation of diastolic dysfunction in
comparison to current velocity based echocardiographic
parameters: total average diastolic LD looks at the entire
diastolic process as it takes the shape of the E and A
diastolic waves, and not just peak values, into consider-
ation. This is illustrated in Fig. 3 where controls and
patients with LV hypertrophy have a preserved total
average diastolic dysfunction despite being classified as
having abnormal relaxation. A compensatory mechanism
that is not measured by current diastolic evaluation
methods could, potentially, be at work. An analysis of
the configuration of the E- and A-waves in controls and
in patients with LV hypertrophy and an abnormal relax-
ation pattern (Table 3) reveals that preserved diastolic
LD is not due to a compensatory increase in overall
A-wave size, as one might anticipate, but is due to E-
waves being low and broad in shape and A-waves being
high and narrow in shape, a situation that is not taken
into consideration when just looking at peak velocities.
Fig. 5 Interchangeability of average systolic displacement and total average diastolic longitudinal displacement. CV, coefficient of variation; SD,
standard deviation
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An analysis of the various heart conditions of the
patients included in this study reveals that total average
diastolic LD is a potential indicator of diastolic dysfunc-
tion irrespective of the primary heart condition, as
discussed below:
With regards to the control group, as expected, the
majority of patients are categorised as having either
normal diastolic function or grade 1 diastolic dysfunc-
tion. An unexpected finding, however, is that the major-
ity of control patients with grade 1 diastolic dysfunction
have a diastolic LD >10 mm. On further analysis, these
individuals did not have enlarged left atriums and the
sole reason for these individuals being classified as
having grade 1 diastolic dysfunction was a LA volume
<34 ml/m2. The majority of these patients also had an
E/A ratio <0.8.
With regard to patients with severe systolic heart
failure, it is questionable how a patient with severely
reduced systolic function (eyeball LVEF <30 %) can have
a preserved diastolic function as, with regards to
conventional understanding, a reduced systolic function
should result in a reduced diastolic function and vice
versa. A closer inspection of these patients revealed that
the individuals with a diastolic LD >10 mm had reduced
markers of systolic function, though greater than indi-
viduals with a diastolic LD <10 mm.
With regards to patients with LV hypertrophy, a pre-
served total average diastolic LD is seen despite patients
being categorised as having an abnormal relaxation
pattern, indicating that total average diastolic LD may
not be optimal for the discernment of diastolic dysfunc-
tion in this patient group. As described above, an
analysis of the E- and A-waves of these patients (Table 3)
reveals broad E-waves and tall, narrow A-waves. For
subjects with LV hypertrophy and grade 1 and 2 diastolic
dysfunction (Table 4), a moderate correlation was found
between total average systolic LD and total average
diastolic LD as well as between s’ and total average
Table 6 Unadjusted and adjusted univariable and multivariable odds ratios
Unadjusted model: Multivariable model adjusted for age
and gender:
Multivariable model adjusted for age, gender,
LVEF, LVIDd/BSA, LVMI, LS:
Odds ratio (95 % CI) P-value Odds ratio (95 % CI) P-value Odds ratio (95 % CI) P-value
TT-e’ + TT-a’ per 1 mm decrease 1.47 (1.26–1.71) <0.001 1.33 (1.13–1.57) <0.01 1.35 (1.04–1.74) <0.05
TT-e’ per 1 mm decrease 1.63 (1.30–2.04) <0.001 1.39 (1.07–1.80) <0.05 1.18 (0.82–1.69) 0.374
TT-a’ per 1 mm decreasea 1.59 (1.26–2.03) <0.001 1.51 (1.16–1.95) <0.01 1.38 (1.01–1.88) <0.05
TT-s’ per 1 mm decrease 1.31 (1.16–1.48) <0.001 1.18 (1.03–1.36) <0.05 1.05 (0.83–1.33) 0.703
-e’ per 1 cm/s decrease 1.70 (1.34–2.15) <0.001 1.41 (1.07–1.85) <0.05 1.24 (0.90–1.72) 0.192
-a’ per 1 cm/s decreasea 1.45 (1.20–1.73) <0.001 1.35 (1.10–1.65) <0.01 1.25 (0.99–1.58) 0.066
-e’ + a’ per 1 cm/s decrease 1.42 (1.24–1.62) <0.001 1.30 (1.12–1.51) <0.01 1.27 (1.04–1.55) <0.05
Per degree of DDF:
• No DDF - - - - - -
• DDF 1 2.26 (0.80–6.38) 0.124 0.76 (0.22–2.58) 0.658 0.39 (0.10–1.50) 0.171
• DDF 2 5.44 (1.91–15.52) <0.01 1.59 (0.48–5.26) 0.451 0.80 (0.21–3.02) 0.744
• DDF 3 1.17 (0.13–10.72) 0.892 0.59 (0.06–5.94) 0.652 0.21 (0.02–2.51) 0.216
E/e’ per 1 unit decrease 1.09 (1.04–1.14) <0.001 1.05 (1.01–1.09) <0.05 1.04 (1.00–1.09) 0.058
E/A per 1 unit decrease 1.04 (0.61–1.79) 0.881 1.43 (0.78–2.60) 0.248 1.28 (0.69–2.37) 0.432
DT per 1 ms decrease 1.00 (1.00–1.01) 0.921 1.00 (0.99–1.00) 0.535 1.00 (1.00–1.01) 0.997
LAD per 1 cm decrease 1.56 (0.53–4.63) 0.420 1.85 (0.42–8.19) 0.420 - -
LA volume per 1 ml/m2 decrease 1.05 (1.02–1.08) <0.001 1.04 (1.01–1.07) <0.05 1.05 (1.01–1.09) <0.05
Per change in patient subgroup:
• Control - - - - - -
• Cardiac dysfunction 9.08 (1.07–77.08) <0.05 3.75 (0.39–36.30) 0.253 1.01 (0.07–15.01) 0.993
• LV hypertrophy 5.46 (0.61–48.53) 0.128 1.89 (0.19–18.79) 0.586 1.06 (0.09–12.34) 0.966
• LV dilation 27.79 (3.35–230.35) <0.01 7.49 (0.83–67.96) 0.073 0.75 (0.03–18.18) 0.859
• Mitral regurgitation 18 (2.15–150.46) <0.01 7.19 (0.79–65.87) 0.081 3.88 (0.39–38.60) 0.248
DDF Degree of diastolic dysfunction, e’ early mitral annular diastolic velocity, TT-e’ displacement in early diastole, a’ late mitral annular diastolic velocity, TT-a’
displacement in late diastole, TT-e’ + TT-a’ total average diastolic displacement, s’ mitral annular systolic velocity, TT-s’ total average systolic displacement, DT
deceleration time, LAD left atrial diameter, LA left atrial
aInteraction with subgroup type
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diastolic LD indicating a potentially preserved systolic
function and reduced diastolic function, as would be ex-
pected in patients with LV hypertrophy. An examination
of parameters of systolic function indicates slightly
reduced systolic function.
With regards to patients with LV dilation and mitral
regurgitation, the expected pattern of falling diastolic LD
with increasing grades of diastolic dysfunction is seen.
No patients with LV dilation have normal diastolic func-
tion, as is to be expected.
Systolic and diastolic function
LV systolic dysfunction is commonly differentiated from
LV diastolic dysfunction by the presence of a reduced
LVEF [17, 18]. This differentiation is potentially erroneous
as abnormalities of contractile function and diastolic dys-
function have been shown to coexist, and diastolic dys-
function often has its genesis in systole [19]. The idea of
isolated diastolic function can, therefore, be questioned
and it can be suggested that heart failure should be viewed
as an individual disease where systolic and diastolic dys-
function are the extremes on a spectrum of different phe-
notypes of the same disease [19, 20]. In this study, systolic
and diastolic function are shown to go hand-in-hand, i.e. a
patient with poor systolic function is also shown to have
poor diastolic function. This relationship is clearly
depicted when using total average diastolic LD as a
marker of diastolic dysfunction (Fig. 4), indicating that LD
is a potentially valid substitute for present velocity-based
determinations of diastolic dysfunction.
Likewise, it is relevant to test the correlation between
average systolic LD and total average diastolic LD as,
intuitively, heart LD in systole must equal heart LD in
diastole if the heart is to remain the same overall size.
Good associations were found with regards to total
average diastolic LD and measurements of systolic heart
function such as peak systolic velocity (s’), systolic LD
(TT-s’), M-mode derived MAPSE and 2D strain derived
LD (Table 5). This finding, as well as the relationship
seen between LVEF and total average diastolic dysfunc-
tion in Fig. 4, also challenges the concept of isolated
diastolic dysfunction. It would be correct to classify
patients with reduced diastolic function and preserved
LVEF as patients with heart failure with preserved
ejection fraction (HFPEF) but incorrect to assume that
these patients have isolated diastolic dysfunction as we
found that systolic function, determined by longitudinal
deformation measurements such as s’ and LS, was
reduced in these patients despite a preserved LVEF. This
indicates that diastolic LD may additionally be a marker
of systolic function that is more sensitive than LVEF.
Despite acceptable correlations between total average
diastolic LD and measurements of systolic heart function
(Table 5), it can be seen that echocardiographic systolic
measurements are not identical to diastolic measure-
ments. This may be partially due to the presence of
L-waves which were not included in the assessment of
diastolic LD as only E- and A-waves were evaluated.
L-waves are often observed in mid-diastole and indicate
continued pulmonary vein flow through the left atrium
Fig. 6 Roc curves illustrating a parameter’s predictive value of death. e’, early diastolic tissue velocity by TDI measured at the mitral annulus; a’, late
diastolic tissue velocity by TDI measured at the mitral annulus; TT-e’, early diastolic displacement measured at the mitral annulus; TT-a’, late diastolic
displacement measured at the mitral annulus; LA, left atrial
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into the left ventricle after the E-wave [21]. Furthermore,
the discrepancy between total average diastolic LD and
systolic heart function may indicate that the relationship
between early and late diastole may reveal aspects of
heart pump function that cannot be revealed by an
assessment of systolic function alone.
Interchangeability and reproducibility of displacement
measurements
Average systolic LD was found to slightly underestimate
total average diastolic LD by approximately 0.6 mm
(Fig. 5). Even though limits of agreement are wide
(±3.46 mm), a CV of 19 % suggests that these two
parameters are potentially interchangeable.
Furthermore, as is shown in Table 5, the correlation
between average diastolic peak velocity measurements
and total average diastolic LD was very good and a
similar relationship of e’ + a’ with the degree of diastolic
dysfunction compared to TT-e’ + TT-a’ and the degree
of diastolic function was found, albeit a cut-off of
12 cm/s is more appropriate here instead of 10 mm
(Additional file 1: Figure S3). Furthermore, area under
the curve illustrating the predictive value of TT-e’ +
TT-a’ and e’ + a’ was very similar. As total average
diastolic LD is a little tricky and time consuming to
measure, average diastolic peak velocity measurements
seems to be a valid substitute.
Reproducibility of displacement measurements of E-
and A-waves was reasonable, taking into consideration
that this is the first time that diastolic LD by colour TDI
has been validated, and was fairly equal in the determin-
ation of both intra and interobserver variability. Limits
of agreement were fairly wide and the largest variability
was seen in the determination of displacement of the
lateral A-wave.
Prediction of adverse cardiac outcomes
An analysis of death as an endpoint, using odds ratios
and ROC curve analyses, showed that risk of death per
unit decrease in both average diastolic LD (TT-e’ +
TT-a’) and average peak diastolic velocities (e’ + a’) was
similar, even after adjustment for covariates.
Clinical implications
Total average diastolic LD has the potential to revolu-
tionise the way in which we look at diastolic function. It
looks at the entire diastolic process, therefore, making it
a promising and sensitive marker of diastolic function.
Furthermore, it has the potential to be used in a clinical
setting as a quick and effective determinant of patients
with and without diastolic dysfunction.
Study limitations
A variety of limitations in this study have to be addressed:
Firstly, the validity of total average diastolic LD was
measured against determinants from current guidelines
for the non-invasive determination of diastolic dysfunc-
tion as the golden standard. Future research with the
use of invasive diastolic measurements is, therefore,
required.
Secondly, only the septal and lateral wall in the
4-chamber view was assessed. A truer (but also much
more time-consuming) depiction of global longitudinal
diastolic performance would be obtained if the anterior,
inferior, posterior and anteroseptal mitral annular sites
were included.
Thirdly, all-cause mortality was the only primary
endpoint evaluated in this study. An assessment of more
endpoints, including cardiovascular death, may show the
prognostic value of total average diastolic LD to be even
higher.
Conclusions
Total average diastolic LD is a promising alternative to
current algorithm-based evaluations. It has a linear rela-
tionship with the degree of diastolic dysfunction assessed
by current guidelines and a 10 mm threshold in total
average diastolic LD can potentially be used independ-
ently to evaluate patients with and without diastolic
dysfunction in a variety of different heart conditions
with reasonable intra and interobserver reproducibility.
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diastolic dysfunction. Figure S3. Total average diastolic velocity and
degree of diastolic dysfunction. Dotted line at 12 cm/s represents cutoff
to discern normal diastolic function from diastolic dysfunction. Figure
S4. Reproducibility of early and late diastolic displacement
measurements. (DOCX 313 kb)
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